Neurogene Inc.NGNENASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank78
3Y CAGR-21.5%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-21.5%/yr
vs +43.8%/yr prior
Acceleration
-65.3pp
Decelerating
Percentile
P78
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 8.75% |
| Q2 2025 | -0.63% |
| Q1 2025 | -20.49% |
| Q4 2024 | 3.01% |
| Q3 2024 | -10.16% |
| Q2 2024 | -7.22% |
| Q1 2024 | -27.46% |
| Q4 2023 | 3.19% |
| Q3 2023 | -20.82% |
| Q2 2023 | 3.37% |
| Q1 2023 | 8.53% |
| Q4 2022 | -9.62% |
| Q3 2022 | 18.09% |
| Q2 2022 | -3.29% |
| Q1 2022 | -1.26% |
| Q4 2021 | 1.80% |
| Q3 2021 | -2.17% |
| Q2 2021 | -1.18% |
| Q1 2021 | -18.28% |
| Q4 2020 | -25.43% |
| Q3 2020 | -3.14% |
| Q2 2020 | -7.69% |
| Q1 2020 | -9.87% |
| Q4 2019 | 28.83% |
| Q3 2019 | -420.65% |
| Q2 2019 | 5.55% |
| Q1 2019 | 45.14% |
| Q4 2018 | 35.79% |
| Q3 2018 | -368.96% |
| Q2 2018 | 116.58% |
| Q1 2018 | 9.16% |
| Q4 2017 | -36.97% |
| Q3 2017 | 13.75% |
| Q2 2017 | -64.22% |
| Q1 2017 | 25.66% |
| Q4 2016 | -38.39% |
| Q3 2016 | 0.00% |